on a mobile?
 
vTap
    Loading...
 
 
Video
Malvinder Singh says Daiichi Sankyo was aware of the US FDA issue before the deal was signed.
4 months ago
CNN-IBN (India)
Keep this video in the "Saved" list
Now, put vTap to work for you!
Let us keep you up to date with new videos related to:
Daiichi Sankyo Co.
Go to Feed to see what's new!
share
keep
 
 
Ranbaxy will probably accept Daiichi Sankyo's buyout offer, predicts Aadil Ebrahim, investment manager at Bowen Capital Management. He revie...
4m 12s |
4 months ago
CNBC Video Gallery - CNBC.com
Keep this video in the "Saved" list
Now, put vTap to work for you!
Let us keep you up to date with new videos related to:
Ranbaxy Laboratories
Investment management
Don Revie
Daiichi Sankyo Co.
Go to Feed to see what's new!
share
keep
 
 
India's largest pharma company is being investigated in the US for alleged fraud.
4 months ago
CNN-IBN (India)
Keep this video in the "Saved" list
Now, put vTap to work for you!
Let us keep you up to date with new videos related to:
Ranbaxy Laboratories
Go to Feed to see what's new!
share
keep
 
 
4 months ago
NDTV.COM
Keep this video in the "Saved" list
Now, put vTap to work for you!
Let us keep you up to date with new videos related to:
Ranbaxy Laboratories
Go to Feed to see what's new!
share
keep
 
 
...Reuters India Investment Summit in Mumbai on Thursday, says the drug maker will "continue to evaluate opportunities for acquisitions not only internationally, but also in India." Speaker: ...
2m 24s |
11 months ago
REUTERS Japan
Keep this video in the "Saved" list
Now, put vTap to work for you!
Let us keep you up to date with new videos related to:
Ranbaxy Laboratories
Go to Feed to see what's new!
share
keep
 
 
More Videos
 
Keep this video in the "Saved" list
Go to Feed to see what's new!
share
keep
 
 
 
 
Jul 16 - Ranbaxy Laboratories Ltd's deal for a takeover by Japan's Daiichi Sankyo remains on track and the Indian firm will give U.S. authorities all information needed for a probe within the next month, it said on Wednesday. U.S. authorities have alleged Ranbaxy, India's top drug maker by sales, introduced adulterated and misbranded drugs in the United States. Devidutta Tripathy, Reuters New Delhi Equities Correspondent, gives us an analysis.
1m 7s |
4 months ago
Reuters
Keep this video in the "Saved" list
Now, put vTap to work for you!
Let us keep you up to date with new videos related to:
Ranbaxy Laboratories
Daiichi Sankyo Co.
United States
Go to Feed to see what's new!
share
keep
 
 

Corporate Home Corporate Home News FAQ About Contact Forums
Privacy Policy and Terms of Use